A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
EpicentRx, Inc.
Advaxis, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Chonnam National University Hospital
Emory University
University of Washington
Sunesis Pharmaceuticals
AHS Cancer Control Alberta
HealthPartners Institute
Valerio Therapeutics
Valerio Therapeutics
Bayer
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Astellas Pharma Inc
Eli Lilly and Company